Catégorie : Bibliographie

Source: Ministère de la Santé et de la Prévention

Feuille de route stratégie nationale de santé sexuelle – 2021-2024

Synthèse stratégie nationale de santé sexuelle – 2021-2024

Source: Ministère de la Santé et de la Prévention

Feuille de route stratégie nationale de santé sexuelle – 2021-2024

Synthèse stratégie nationale de santé sexuelle – 2021-2024

Gerard H. A. Visser,corresponding author 1 , 2 Trude Thommesen, 2 , 3 Gian Carlo Di Renzo, 2 Anwar H. Nassar, 1 Steven L. Spitalnik, 2 and FIGO Committee for Safe Motherhood, Newborn Health

Int J Gynaecol Obstet. 2021 Feb; 152(2): 144–147.

Published online 2021 Jan 9. doi: 10.1002/ijgo.13459
PMCID: PMC7898700
PMID: 33128246

FIGO/ICM guidelines for preventing Rhesus disease: A call to action

Gerard H. A. Visser,corresponding author 1 , 2 Trude Thommesen, 2 , 3 Gian Carlo Di Renzo, 2 Anwar H. Nassar, 1 Steven L. Spitalnik, 2 and FIGO Committee for Safe Motherhood, Newborn Health

Author information Article notes Copyright and License information Disclaimer
Go to:

Abstract
The introduction of anti‐Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti‐Rh(D) immunoglobulin. Taking into account the effectiveness anti‐Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication.

Keywords: Anti‐D immunoglobulin, FIGO, Guidelines, International Confederation of Midwives, Prophylaxis, Rhesus disease, Worldwide Initiative for Rhesus Disease Eradication

Author Noémie Roland Jérôme Drouin David Desplas Lise Duranteau François Cuenot Rosemary Dray-Spira Alain Weill Mahmoud Zureik

Source: Science direct

Source: ORS
Date de publication 28 mars 2022